Home › NDC Lookup › RxCUI directory › RxCUI 647121

5 ML levetiracetam 100 MG/ML Injection — RxCUI 647121

RxNorm drug concept · Semantic clinical drug
RxCUI 647121 Semantic clinical drug · SCD ● Current RxNorm concept 20 FDA products 29 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI647121
Official name5 ML levetiracetam 100 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevetiracetam 500 MG per 5 ML Injection; levETIRAcetam 500 MG in 5 ML Injection
FDA products mapped20
Package NDCs mapped29
Reported Medicaid activity (SDUD)16,644 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levetiracetam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Levetiracetam is an anti-seizure medicine. Depending on the product and your age, it can be used to treat partial-onset seizures (seizures starting in one part of the brain), myocl...
  • What is levetiracetam actually used for?
  • It can, especially when you first start taking it. Drowsiness, fatigue, and dizziness are among the most common side effects and tend to be most noticeable in the first few weeks....
  • Will levetiracetam make me feel tired or foggy?
📖 Read our full Levetiracetam guide →

🕸️ Concept Web — How 5 ML levetiracetam 100 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 5 ML levetiracetam 100 MG/ML Injection RxCUI 647121

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Levetiracetam 114477
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Keppra 261547
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Levetiracetam Injection 1790330
    • Levetiracetam Injectable Product 1163449
    • Levetiracetam Injection [Keppra] 1790332
    • Keppra Injectable Product 1170052
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Levetiracetam 100 MG/ML SCDC · 406092
  • Levetiracetam Injection SCDF · 1790330
  • Levetiracetam Injectable Product SCDG · 1163449

Brand-Name Concepts

📦 FDA Products & Package NDCs

20 products · 29 package NDCs
29 package NDCs map to RxCUI 647121 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9574-10 10 VIAL, SINGLE-DOSE in 1 CARTON (0143-9574-10) / 5 mL in 1... Levetiracetam Hikma Pharmaceuticals USA Inc. 2015-06-01
00143-9574-25 25 VIAL, SINGLE-DOSE in 1 CARTON (0143-9574-25) / 5 mL in 1... Levetiracetam Hikma Pharmaceuticals USA Inc. 2015-06-01
00143-9673-10 10 VIAL, GLASS in 1 BOX (0143-9673-10) / 5 mL in 1 VIAL, GL... Levetiracetam Hikma Pharmaceuticals USA Inc. 2011-10-13
00143-9673-25 25 VIAL, GLASS in 1 CARTON (0143-9673-25) / 5 mL in 1 VIAL,... Levetiracetam Hikma Pharmaceuticals USA Inc. 2011-10-13
00409-1886-02 25 VIAL, SINGLE-DOSE in 1 CARTON (0409-1886-02) / 5 mL in 1... LEVETIRACETAM Hospira, Inc. 2012-11-02
00409-2011-25 25 VIAL, SINGLE-DOSE in 1 CARTON (0409-2011-25) / 5 mL in 1... LEVETIRACETAM Hospira, Inc. 2021-11-01
25021-0780-05 10 VIAL in 1 CARTON (25021-780-05) / 5 mL in 1 VIAL Levetiracetam Sagent Pharmaceuticals 2013-11-01
42571-0331-92 10 VIAL in 1 CARTON (42571-331-92) / 5 mL in 1 VIAL LEVETIRACETAM Micro Labs Limited 2019-10-04
43547-0454-10 10 VIAL, SINGLE-DOSE in 1 CARTON (43547-454-10) / 5 mL in 1... LEVETIRACETAM Solco Healthcare US, LLC 2022-04-11
50474-0002-63 10 VIAL, SINGLE-USE in 1 CARTON (50474-002-63) / 5 mL in 1... Keppra UCB, Inc. 2006-08-23
51224-0013-10 10 VIAL, SINGLE-USE in 1 CARTON (51224-013-10) / 5 mL in 1... Levetiracetam TAGI Pharma, Inc. 2018-11-30
51224-0013-25 25 VIAL, SINGLE-USE in 1 CARTON (51224-013-25) / 5 mL in 1... Levetiracetam TAGI Pharma, Inc. 2018-11-30
55150-0177-05 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-177-05) / 5 mL in 1... Levetiracetam Eugia US LLC 2016-02-01
58657-0860-01 1 VIAL, SINGLE-DOSE in 1 CARTON (58657-860-01) / 5 mL in 1... LEVETIRACETAM Method Pharmaceuticals, LLC 2025-12-15
58657-0860-10 10 VIAL, SINGLE-DOSE in 1 CARTON (58657-860-10) / 5 mL in 1... LEVETIRACETAM Method Pharmaceuticals, LLC 2025-12-15
58657-0860-25 25 VIAL, SINGLE-DOSE in 1 CARTON (58657-860-25) / 5 mL in 1... LEVETIRACETAM Method Pharmaceuticals, LLC 2025-12-15
63323-0400-05 10 VIAL, SINGLE-USE in 1 TRAY (63323-400-05) / 5 mL in 1 VI... Levetiracetam Fresenius Kabi USA, LLC 2015-08-13
63323-0400-44 10 VIAL, SINGLE-USE in 1 TRAY (63323-400-44) / 5 mL in 1 VI... Levetiracetam Fresenius Kabi USA, LLC 2015-08-13
67457-0790-05 10 VIAL, SINGLE-DOSE in 1 CARTON (67457-790-05) / 5 mL in 1... levetiracetam Mylan Institutional LLC 2017-07-24
68094-0313-10 10 VIAL, SINGLE-USE in 1 CARTON (68094-313-10) / 5 mL in 1... Levetiracetam Precision Dose, Inc. 2024-10-10
68094-0313-25 25 VIAL, SINGLE-USE in 1 CARTON (68094-313-25) / 5 mL in 1... Levetiracetam Precision Dose, Inc. 2024-10-10
72162-2638-02 10 VIAL in 1 CARTON (72162-2638-2) / 5 mL in 1 VIAL Levetiracetam Bryant Ranch Prepack 2026-05-06
72162-2638-04 25 VIAL in 1 CARTON (72162-2638-4) / 5 mL in 1 VIAL Levetiracetam Bryant Ranch Prepack 2026-05-06
72205-0120-07 10 VIAL in 1 CARTON (72205-120-07) / 5 mL in 1 VIAL Levetiracetam Novadoz Pharmaceuticals LLC 2023-02-09
72205-0120-25 25 VIAL in 1 CARTON (72205-120-25) / 5 mL in 1 VIAL Levetiracetam Novadoz Pharmaceuticals LLC 2023-02-09
72485-0106-10 10 VIAL, SINGLE-DOSE in 1 CARTON (72485-106-10) / 5 mL in 1... LEVETIRACETAM Armas Pharmaceuticals Inc. 2021-01-14
72485-0106-25 25 VIAL, SINGLE-DOSE in 1 CARTON (72485-106-25) / 5 mL in 1... LEVETIRACETAM Armas Pharmaceuticals Inc. 2023-03-16
72572-0360-25 25 VIAL in 1 CARTON (72572-360-25) / 5 mL in 1 VIAL (72572-... Levetiracetam Civica, Inc. 2022-12-01
85957-0037-02 10 VIAL in 1 CARTON (85957-037-02) / 5 mL in 1 VIAL (85957-... Levetiracetam Aryeh Pharma corp 2026-04-10
Observed labelers: Hikma Pharmaceuticals USA Inc. (4) · Method Pharmaceuticals, LLC (3) · Armas Pharmaceuticals Inc. (2) · Bryant Ranch Prepack (2) · Fresenius Kabi USA, LLC (2) · Hospira, Inc. (2) · +11 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1953 Levetiracetam injection 15 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.